LONDON, February 6, 2017 /PRNewswire/ --
The global interventional cardiology market is expected to grow at a CAGR of 11.1% in the first half of the forecast period and CAGR of 16.9% in the second half of the forecast period. The market is expected to grow at a CAGR of 15.0% from 2017 to 2027. The market is estimated at $13,920m in 2021 and $35,537m in 2027.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 225-page report you will receive 111 charts - all unavailable elsewhere.
The 225-page report provides clear detailed insight into the global interventional cardiology market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Interventional Cardiology Market forecasts from 2017-2027
• Percutaneous Coronary Intervention (PCI) submarket forecasts from 2017-2027, further segmented into: - Drug-eluting Stents (DES) - Bare Metal Stents - Bioresorbable Stents
This section also discusses the leading products, competitive landscape, market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for PCI in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Transcatheter Aortic Valve Implantation (TAVI/TAVR) from 2017-2027 This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TAVI/TAVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
To see a report overview please email Sara Peerun on [email protected]
• Trans Mitral Valve Implantation (TMVR) submarket forecasts from 2017-2027 This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TMVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Interventional Cardiology Leading National Market forecasts from 2017-2027 covering the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China, India and the Rest of the World (RoW)
Each country is further segmented into PCI, TAVI and TMVR.
• Assessment of selected leading companies that hold major market shares in the interventional cardiology market
• SWOT and STEP analysis of the global interventional cardiology market
Visiongain's study is intended for anyone requiring commercial analyses for the Global Interventional Cardiology Market. You find data, trends and predictions.
Buy our report today Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR).
To request a report overview of this report please emails Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100
Or click on : https://www.visiongain.com/Report/1786/Global-Interventional-Cardiology-Market-2017-2027
List of Companies and Organisations Mentioned in the Report
3mensio Medical Imaging
Abbott
Accucinch
Alvimedica
Amaranth Medical
Aperture Venture Partners
Arterial Remodelling Technologies
B.Braun
Balton
Biosensors International
Biotronik
Boston Scientific Group
British Heart Foundation
Caisson
Cardiac Dimensions
CardiAQ
Cardica
Cardiosolutions
Centre for Disease and Prevention Control (CDC)
Centres for Medicare & Medicaid Services
Cordis
Direct Flow Medical
Edwards Lifesciences
Elixir Medical Corporation
Emory University
European Society for Cardiology
FDA
HighLife
JenaValve
JW Medical Systems
Kardium
Kyoto Medical Planning
Lepu Medical Technology
Life Science Partners
Mardil Medical
Medfavour Medical Co., Ltd.
Medtronic
Micell Technologies
Microport Scientific
Milipede
Ministry of Health Labor and Welfare (MHLW)
Mitralign Inc.
Mitralix
MitrAssist
MVRx
NCSI
Neovasc
OrbusNeich Medical, Inc.
Paieon Inc
Pharmaceuticals and Medical Devices Agency (PDMA)
Phillips
Reva Medical
Sahajanand Medical Technologies Pvt.
Shanghai MicroPort Medical (Group) Co., Ltd.
Siemens AG
Singapore Heart Foundation
St Jude Medical
Surmodics Inc.
Sysmetis
Tendyne Holdings, Inc.
Terumo
The Health Science Authority (HSA)
The Medical Services Advisory Committee (MSAC)
TransCardiac
Valtech Cardio
Vascular Concepts
Venus Medtech Inc.,
WHO
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
Advertisement
Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR)
Advertisement
The global interventional cardiology market is expected to grow at a CAGR of 11.1% in the first half of the forecast period and CAGR of 16.9% in the second half of the forecast period. The market is expected to grow at a CAGR of 15.0% from 2017 to 2027. The market is estimated at $13,920m in 2021 and $35,537m in 2027.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 225-page report you will receive 111 charts - all unavailable elsewhere.
The 225-page report provides clear detailed insight into the global interventional cardiology market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Interventional Cardiology Market forecasts from 2017-2027
• Percutaneous Coronary Intervention (PCI) submarket forecasts from 2017-2027, further segmented into: - Drug-eluting Stents (DES) - Bare Metal Stents - Bioresorbable Stents
This section also discusses the leading products, competitive landscape, market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for PCI in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Transcatheter Aortic Valve Implantation (TAVI/TAVR) from 2017-2027 This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TAVI/TAVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
To see a report overview please email Sara Peerun on [email protected]
• Trans Mitral Valve Implantation (TMVR) submarket forecasts from 2017-2027 This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TMVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
• Interventional Cardiology Leading National Market forecasts from 2017-2027 covering the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China, India and the Rest of the World (RoW)
Each country is further segmented into PCI, TAVI and TMVR.
• Assessment of selected leading companies that hold major market shares in the interventional cardiology market
• SWOT and STEP analysis of the global interventional cardiology market
Visiongain's study is intended for anyone requiring commercial analyses for the Global Interventional Cardiology Market. You find data, trends and predictions.
Buy our report today Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR).
To request a report overview of this report please emails Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100
Or click on : https://www.visiongain.com/Report/1786/Global-Interventional-Cardiology-Market-2017-2027
List of Companies and Organisations Mentioned in the Report
3mensio Medical Imaging
Abbott
Accucinch
Alvimedica
Amaranth Medical
Aperture Venture Partners
Arterial Remodelling Technologies
B.Braun
Balton
Biosensors International
Biotronik
Boston Scientific Group
British Heart Foundation
Caisson
Cardiac Dimensions
CardiAQ
Cardica
Cardiosolutions
Centre for Disease and Prevention Control (CDC)
Centres for Medicare & Medicaid Services
Cordis
Direct Flow Medical
Edwards Lifesciences
Elixir Medical Corporation
Emory University
European Society for Cardiology
FDA
HighLife
JenaValve
JW Medical Systems
Kardium
Kyoto Medical Planning
Lepu Medical Technology
Life Science Partners
Mardil Medical
Medfavour Medical Co., Ltd.
Medtronic
Micell Technologies
Microport Scientific
Milipede
Ministry of Health Labor and Welfare (MHLW)
Mitralign Inc.
Mitralix
MitrAssist
MVRx
NCSI
Neovasc
OrbusNeich Medical, Inc.
Paieon Inc
Pharmaceuticals and Medical Devices Agency (PDMA)
Phillips
Reva Medical
Sahajanand Medical Technologies Pvt.
Shanghai MicroPort Medical (Group) Co., Ltd.
Siemens AG
Singapore Heart Foundation
St Jude Medical
Surmodics Inc.
Sysmetis
Tendyne Holdings, Inc.
Terumo
The Health Science Authority (HSA)
The Medical Services Advisory Committee (MSAC)
TransCardiac
Valtech Cardio
Vascular Concepts
Venus Medtech Inc.,
WHO
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
